Silva Pharmaceuticals Limited (DSE:SILVAPHL)

Silva Pharmaceuticals Statistics

Total Valuation

DSE:SILVAPHL has a market cap or net worth of BDT 1.35 billion. The enterprise value is 1.26 billion.

Market Cap	1.35B
Enterprise Value	1.26B

Important Dates

The next estimated earnings date is Wednesday, January 28, 2026.

Earnings Date	Jan 28, 2026
Ex-Dividend Date	Dec 2, 2024

Share Statistics

DSE:SILVAPHL has 136.50 million shares outstanding.

Current Share Class	136.50M
Shares Outstanding	136.50M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.64
PB Ratio	0.65
P/TBV Ratio	0.65
P/FCF Ratio	66.29
P/OCF Ratio	55.68
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-9.28
EV / Sales	3.40
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	61.86

Financial Position

The company has a current ratio of 13.52, with a Debt / Equity ratio of 0.01.

Current Ratio	13.52
Quick Ratio	5.68
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	1.52
Interest Coverage	-27.53

Financial Efficiency

Return on equity (ROE) is -6.32% and return on invested capital (ROIC) is -3.51%.

Return on Equity (ROE)	-6.32%
Return on Assets (ROA)	-3.34%
Return on Invested Capital (ROIC)	-3.51%
Return on Capital Employed (ROCE)	-5.70%
Revenue Per Employee	538,400
Profits Per Employee	-197,288
Employee Count	615
Asset Turnover	0.16
Inventory Turnover	0.62

Taxes

In the past 12 months, DSE:SILVAPHL has paid 13.21 million in taxes.

Income Tax	13.21M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -8.33% in the last 52 weeks. The beta is -0.05, so DSE:SILVAPHL's price volatility has been lower than the market average.

Beta (5Y)	-0.05
52-Week Price Change	-8.33%
50-Day Moving Average	10.03
200-Day Moving Average	10.76
Relative Strength Index (RSI)	57.13
Average Volume (20 Days)	177,167

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, DSE:SILVAPHL had revenue of BDT 370.96 million and -135.93 million in losses. Loss per share was -1.00.

Revenue	370.96M
Gross Profit	95.40M
Operating Income	-123.07M
Pretax Income	-122.72M
Net Income	-135.93M
EBITDA	-66.62M
EBIT	-123.07M
Loss Per Share	-1.00

Balance Sheet

The company has 121.27 million in cash and 30.99 million in debt, giving a net cash position of 90.28 million or 0.66 per share.

Cash & Cash Equivalents	121.27M
Total Debt	30.99M
Net Cash	90.28M
Net Cash Per Share	0.66
Equity (Book Value)	2.08B
Book Value Per Share	15.22
Working Capital	750.51M

Cash Flow

In the last 12 months, operating cash flow was 24.27 million and capital expenditures -3.88 million, giving a free cash flow of 20.38 million.

Operating Cash Flow	24.27M
Capital Expenditures	-3.88M
Free Cash Flow	20.38M
FCF Per Share	0.15

Margins

Gross margin is 25.72%, with operating and profit margins of -33.18% and -36.64%.

Gross Margin	25.72%
Operating Margin	-33.18%
Pretax Margin	-33.08%
Profit Margin	-36.64%
EBITDA Margin	-17.96%
EBIT Margin	-33.18%
FCF Margin	5.50%

Dividends & Yields

This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 1.02%.

Dividend Per Share	0.10
Dividend Yield	1.02%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	1.02%
Earnings Yield	-10.06%
FCF Yield	1.51%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 7, 2019. It was a forward split with a ratio of 1.05.

Last Split Date	Nov 7, 2019
Split Type	Forward
Split Ratio	1.05

Scores

DSE:SILVAPHL has an Altman Z-Score of 7 and a Piotroski F-Score of 3.

Altman Z-Score	7
Piotroski F-Score	3